This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Brook, I. Articles by Hirokawa, R. Search for Related Content PubMed PubMed Citation Articles by Brook, I. Articles by Hirokawa, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CLINDAMYCIN ERYTHROMYCIN Medline Plus Health Information Streptococcal Infections Tonsils and Adenoids Social Bookmarking                         What's this?

Treatment of Patients with a History of Recurrent Tonsillitis Due to Group A Beta-hemolytic Streptococci

A Prospective Randomized Study Comparing Penicillin, Erythromycin, and Clindamycin

Armed Forces Radio-biology Research Institute, Bethesda, MD 20814

Ronald Hirokawa

Forty-five patients with a history of recurrent tonsillitis associated with Group A beta- hemolytic streptococcal (GABHS) infection participated in a prospective, randomized study comparing penicillin, erythromycin, or clindamycin therapy. Surface tonsillar cultures were obtained before therapy, 10 days after termination of therapy, and once a month for a period of 12 to 18 months. The specimens were processed for aerobic and anaerobic bacteria. Beta lactamase-producing aerobic and anaerobic bacteria were present in 43 of the 45 (96%) tonsillar cultures. GABHS colonization was eradicated in two of 15 patients treated with penicillin, in six of 15 treated with erythromycin, and in 14 of the 15 treated with clindamycin. In long-term follow-up, 12 of 14 patients treated with penicillin, eight of 14 treated with erythromycin, and one of 15 treated with clindamycin (p < 0.0001 when compared to penicillin and p = 0.002 when compared to erythromycin) continued to suffer from recurrent tonsillitis.

Clinical Pediatrics, Vol. 24, No. 6, 331-336 (1985)
DOI: 10.1177/000992288502400606


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				I. Brook Penicillin Failure in the Treatment of Acute and Relapsing Tonsillopharyngitis Is Associated With Copathogens and Alteration of Microbial Balance: A Role for Cephalosporins Clinical Pediatrics, May 1, 2007; 46(4_suppl): 17S - 24S. [Abstract] [PDF]

				I. Brook Effects of antimicrobial therapy on the microbial flora of the adenoids J. Antimicrob. Chemother., June 1, 2003; 51(6): 1331 - 1337. [Abstract] [Full Text] [PDF]

				I. Brook and A. E. Gober Role of Bacterial Interference and {beta}-Lactamase--Producing Bacteria in the Failure of Penicillin to Eradicate Group A Streptococcal Pharyngotonsillitis Arch Otolaryngol Head Neck Surg, December 1, 1995; 121(12): 1405 - 1409. [Abstract] [PDF]

				P. A. Foote Jr and I. Brook Penicillin and Clindamycin Therapy in Recurrent Tonsillitis: Effect of Microbial Flora Arch Otolaryngol Head Neck Surg, July 1, 1989; 115(7): 856 - 859. [Abstract] [PDF]

				I. BROOK and P. FOOTE Microbiology of the Tonsils and Adenoids Arch Otolaryngol Head Neck Surg, April 1, 1989; 115(4): 528 - 528. [Abstract] [PDF]

				R. M. DeDio, L. W. C. Tom, K. L. McGowan, R. F. Wetmore, S. D. Handler, and W. P. Potsic Microbiology of the Tonsils and Adenoids in a Pediatric Population Arch Otolaryngol Head Neck Surg, July 1, 1988; 114(7): 763 - 765. [Abstract] [PDF]

				I. Brook Emergence and Persistence of {beta}-Lactamase--Producing Bacteria in the Oropharynx Following Penicillin Treatment Arch Otolaryngol Head Neck Surg, June 1, 1988; 114(6): 667 - 670. [Abstract] [PDF]